1. Home
  2. |Insights
  3. |GAO Says Strategic Sourcing Benefits Realized, Wants Expansion

GAO Says Strategic Sourcing Benefits Realized, Wants Expansion

Client Alert | less than 1 min read | 11.18.16

Last month, GAO issued a report on strategic sourcing that addresses how successful the Federal Strategic Sourcing Initiative (FSSI) program has been to date. While the report found that, from FY2011-15, agencies reported spending almost $2 billion through the FSSI and claimed $470 million in savings, the report also found that “agencies’ low use of the FSSIs … diminished the potential savings that could have been achieved” – an underutilization that GAO attributed partially to the Strategic Sourcing Leadership Council agencies directing only “10 percent of their collective spending to the FSSIs[,]” with GAO calling for more aggressive targets to be set.

Insights

Client Alert | 3 min read | 03.02.26

Changes to UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions of UK Model Clinical Trial Agreement Forms Pending.

Clinical trial sponsors and all other stakeholders involved in conducting commercial clinical trials of investigational medicinal products (IMP) in the UK....